Skip Nav Destination

Issues

Select Year

Issue

Search within issue:

Search within issue

Diabetes, Obesity and Hypertension Outcome Studies

Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs

Boaz Hirshberg, MD; Itamar Raz, MD

Abstracts

View articletitled, Impact of the U.S. Food and Drug Administration Cardiovascular Assessment Requirements on the Development of Novel Antidiabetes Drugs

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S101-S106. doi:https://doi.org/10.2337/dc11-s202

The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial: What we learn from subgroup analyses

Henry N. Ginsberg, MD

Abstracts

View articletitled, The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial: What we learn from subgroup analyses

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S107-S108. doi:https://doi.org/10.2337/dc11-s203

Diabetes, Hypertension, and Outcome Studies: Overview 2010

Peter M. Nilsson, MD; Jan Cederholm, MD

Abstracts

View articletitled, Diabetes, Hypertension, and Outcome Studies: Overview 2010

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S109-S113. doi:https://doi.org/10.2337/dc11-s204

Sibutramine on Cardiovascular Outcome

André J. Scheen, MD

Abstracts

View articletitled, Sibutramine on Cardiovascular Outcome

Open the PDF for in another window

Topics: sibutramine , cardiovascular system , cardiovascular diseases

Diabetes Care April 2011, Vol.34, S114-S119. doi:https://doi.org/10.2337/dc11-s205

Diabetes and Cardiovascular Disease

Postprandial Hyperglycemia and Glycemic Variability: Should we care?

Eberhard Standl, MD; Oliver Schnell, MD; Antonio Ceriello, MD

Abstracts

View articletitled, Postprandial Hyperglycemia and Glycemic Variability: Should we care?

Open the PDF for in another window

Topics: glucose , postprandial hyperglycemia

Diabetes Care April 2011, Vol.34, S120-S127. doi:https://doi.org/10.2337/dc11-s206

Is Hyperglycemia a Cardiovascular Risk Factor?

Frank Pistrosch, MD; Andrea Natali, MD; Markolf Hanefeld, MD

Abstracts

View articletitled, Is Hyperglycemia a Cardiovascular Risk Factor?

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S128-S131. doi:https://doi.org/10.2337/dc11-s207

Hypoglycemia and Cardiovascular Risks

Brian M. Frier, MD; Guntram Schernthaner, MD; Simon R. Heller, MD

Abstracts

View articletitled, Hypoglycemia and Cardiovascular Risks

Open the PDF for in another window

Topics: hypoglycemia

Diabetes Care April 2011, Vol.34, S132-S137. doi:https://doi.org/10.2337/dc11-s220

Heart in Diabetes: Not Only a Macrovascular Disease

Bernd Stratmann, PHD; Diethelm Tschoepe, MD

Abstracts

View articletitled, Heart in Diabetes: Not Only a Macrovascular Disease

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S138-S144. doi:https://doi.org/10.2337/dc11-s208

Heart in Diabetes: A Microvascular Disease

Markku Laakso, MD

Abstracts

View articletitled, Heart in Diabetes: A Microvascular Disease

Open the PDF for in another window

Topics: cardiomyopathy , cardiovascular diseases , diabetes mellitus complications , diabetes mellitus, type 2 , heart

Diabetes Care April 2011, Vol.34, S145-S149. doi:https://doi.org/10.2337/dc11-s209

Antiplatelet Therapy for Every Diabetic Person?

Antonio Nicolucci, MD; Eberhard Standl, MD

Abstracts

View articletitled, Antiplatelet Therapy for Every Diabetic Person?

Open the PDF for in another window

Topics: antiplatelet agents , aspirin , cardiovascular event , primary prevention , ischemic stroke

Diabetes Care April 2011, Vol.34, S150-S154. doi:https://doi.org/10.2337/dc11-s210

Should C-Reactive Protein Be a Target of Therapy?

Jisun Oh, MD; Hwee Teoh, PHD; Lawrence A. Leiter, MD

Abstracts

View articletitled, Should C-Reactive Protein Be a Target of Therapy?

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S155-S160. doi:https://doi.org/10.2337/dc11-s211

Diabetes

Type 2 Diabetes in Youth: Epidemiology and Pathophysiology

Ebe D’Adamo, MD; Sonia Caprio, MD

Abstracts

View articletitled, Type 2 Diabetes in Youth: Epidemiology and Pathophysiology

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S161-S165. doi:https://doi.org/10.2337/dc11-s212

Obesity, Autoimmunity, and Double Diabetes in Youth

Paolo Pozzilli, MD; Chiara Guglielmi, MD; Sonia Caprio, MD; Raffaella Buzzetti, MD

Abstracts

View articletitled, Obesity, Autoimmunity, and Double Diabetes in Youth

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S166-S170. doi:https://doi.org/10.2337/dc11-s213

Childhood Metabolic Syndrome: Must we define it to deal with it?

Ram Weiss, MD

Abstracts

View articletitled, Childhood Metabolic Syndrome: Must we define it to deal with it?

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S171-S176. doi:https://doi.org/10.2337/dc11-s214

Treatment of Type 2 Diabetes in Youth

Amanda Flint, MD; Silva Arslanian, MD

Abstracts

View articletitled, Treatment of Type 2 Diabetes in Youth

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S177-S183. doi:https://doi.org/10.2337/dc11-s215

The Pros and Cons of Diagnosing Diabetes With A1C

Enzo Bonora, MD; Jaakko Tuomilehto, MD

Abstracts

View articletitled, The Pros and Cons of Diagnosing Diabetes With A1C

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S184-S190. doi:https://doi.org/10.2337/dc11-s216

Should A1C Targets Be Individualized for All People With Diabetes?: Arguments for and against

Hwee Teoh, PHD; Philip Home, DM; Lawrence A. Leiter, MD

Abstracts

View articletitled, Should A1C Targets Be Individualized for All People With Diabetes?: Arguments for and against

Open the PDF for in another window

Topics: diabetes mellitus, type 2 , glycemic control , hypoglycemia , insulin , hypoglycemic agents

Diabetes Care April 2011, Vol.34, S191-S196. doi:https://doi.org/10.2337/dc11-s217

Current Application of Continuous Glucose Monitoring in the Treatment of Diabetes: Pros and cons

Jeroen Hermanides, MD; Moshe Phillip, MD,; J. Hans DeVries, MD,

Abstracts

View articletitled, Current Application of Continuous Glucose Monitoring in the Treatment of Diabetes: Pros and cons

Open the PDF for in another window

Topics: continuous glucose monitoring , hemoglobin a, glycosylated

Diabetes Care April 2011, Vol.34, S197-S201. doi:https://doi.org/10.2337/dc11-s219

Diabetes Treatments

Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention

Ralph A. DeFronzo, MD; Muhammad Abdul-Ghani, MD

Abstracts

View articletitled, Type 2 Diabetes Can Be Prevented With Early Pharmacological Intervention

Supplementary data

Open the PDF for in another window

Topics: diabetes mellitus, type 2 , pharmacotherapy , metformin , weight reduction

Diabetes Care April 2011, Vol.34, S202-S209. doi:https://doi.org/10.2337/dc11-s221

Long-Term Benefits From Lifestyle Interventions for Type 2 Diabetes Prevention: Time to expand the efforts

Jaakko Tuomilehto, MD; Peter Schwarz, MD; Jaana Lindström, PHD

Abstracts

View articletitled, Long-Term Benefits From Lifestyle Interventions for Type 2 Diabetes Prevention: Time to expand the efforts

Open the PDF for in another window

Topics: diabetes mellitus, type 2 , diabetes prevention , follow-up , life style , diet

Diabetes Care April 2011, Vol.34, S210-S214. doi:https://doi.org/10.2337/dc11-s222

Safety of PPAR Agonists

Philip Home, DM

Abstracts

View articletitled, Safety of PPAR Agonists

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S215-S219. doi:https://doi.org/10.2337/dc11-s233

Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes

Geremia B. Bolli, MD; Paola Lucidi, MD; Francesca Porcellati, MD; Carmine G. Fanelli, MD

Abstracts

View articletitled, Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S220-S224. doi:https://doi.org/10.2337/dc11-s224

Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 Diabetes

Harold E. Lebovitz, MD

Abstracts

View articletitled, Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 Diabetes

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S225-S230. doi:https://doi.org/10.2337/dc11-s225

Multidrug Treatment of Type 2 Diabetes: A challenge for compliance

Roberto Miccoli, MD; Giuseppe Penno, MD; Stefano Del Prato, MD

Abstracts

View articletitled, Multidrug Treatment of Type 2 Diabetes: A challenge for compliance

Open the PDF for in another window

Topics: diabetes mellitus, type 2 , hemoglobin a, glycosylated , glycemic control , patient compliance , clinical inertia

Diabetes Care April 2011, Vol.34, S231-S235. doi:https://doi.org/10.2337/dc11-s235

Glucokinase Activators for Diabetes Therapy: May 2010 status report

Franz M. Matschinsky, MD; Bogumil Zelent, PHD; Nicolai Doliba, PHD; Changhong Li, PHD; Jane M. Vanderkooi, PHD; Ali Naji, PHD; Ramakanth Sarabu, PHD; Joseph Grimsby, PHD

Abstracts

View articletitled, Glucokinase Activators for Diabetes Therapy: May 2010 status report

Supplementary data

Open the PDF for in another window

Topics: diabetes mellitus, type 2 , enzymes , glucokinase , glucose , glucose homeostasis

Diabetes Care April 2011, Vol.34, S236-S243. doi:https://doi.org/10.2337/dc11-s236

Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes

Yehuda Handelsman, MD

Abstracts

View articletitled, Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes

Open the PDF for in another window

Topics: diabetes mellitus, type 2 , colesevelam hydrochloride

Diabetes Care April 2011, Vol.34, S244-S250. doi:https://doi.org/10.2337/dc11-s237

Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

Jens J. Holst, MD; Filip K. Knop, MD; Tina Vilsbøll, MD; Thure Krarup, MD; Sten Madsbad, MD

Abstracts

View articletitled, Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S251-S257. doi:https://doi.org/10.2337/dc11-s227

Incretin Effects on β-Cell Function, Replication, and Mass: The human perspective

Alan J. Garber, MD

Abstracts

View articletitled, Incretin Effects on β-Cell Function, Replication, and Mass: The human perspective

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S258-S263. doi:https://doi.org/10.2337/dc11-s230

Therapy in the Early Stage: Incretins

Simona Cernea, MD; Itamar Raz, MD

Abstracts

View articletitled, Therapy in the Early Stage: Incretins

Open the PDF for in another window

Topics: agonists , dipeptidyl-peptidase iv inhibitors , incretin , diabetes mellitus, type 2 , insulin

Diabetes Care April 2011, Vol.34, S264-S271. doi:https://doi.org/10.2337/dc11-s223

Glycemic Control Impact on Body Weight Potential to Reduce Cardiovascular Risk: Glucagon-like peptide 1 agonists

Giorgio Sesti, MD

Abstracts

View articletitled, Glycemic Control Impact on Body Weight Potential to Reduce Cardiovascular Risk: Glucagon-like peptide 1 agonists

Open the PDF for in another window

Topics: agonists , antidiabetics , diabetes mellitus, type 2 , exenatide , glucagon-like peptide 1

Diabetes Care April 2011, Vol.34, S272-S275. doi:https://doi.org/10.2337/dc11-s228

DPP-4 Inhibitors: Impact on glycemic control and cardiovascular risk factors

Dror Dicker, MD

Abstracts

View articletitled, DPP-4 Inhibitors: Impact on glycemic control and cardiovascular risk factors

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S276-S278. doi:https://doi.org/10.2337/dc11-s229

Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerability

Alan J. Garber, MD

Abstracts

View articletitled, Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerability

Supplementary data

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S279-S284. doi:https://doi.org/10.2337/dc11-s231

Hypertension

Endothelial Dysfunction in Diabetes: The role of reparatory mechanisms

Angelo Avogaro, MD; Mattia Albiero, PHD; Lisa Menegazzo, PHD; Saula de Kreutzenberg, MD; Gian Paolo Fadini, MD

Abstracts

View articletitled, Endothelial Dysfunction in Diabetes: The role of reparatory mechanisms

Open the PDF for in another window

Topics: endothelial dysfunction , endothelium , diabetes mellitus complications , stem cells , ischemia

Diabetes Care April 2011, Vol.34, S285-S290. doi:https://doi.org/10.2337/dc11-s239

Endothelial Factors and Diabetic Nephropathy

Janaka Karalliedde, MRCP; Luigi Gnudi, MD

Abstracts

View articletitled, Endothelial Factors and Diabetic Nephropathy

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S291-S296. doi:https://doi.org/10.2337/dc11-s241

Benefits of Tight Blood Pressure Control in Diabetic Patients With Hypertension: Importance of early and sustained implementation of effective treatment strategies

Gianfranco Parati, MD; Grzegorz Bilo, MD; Juan E. Ochoa, MD

Abstracts

View articletitled, Benefits of Tight Blood Pressure Control in Diabetic Patients With Hypertension: Importance of early and sustained implementation of effective treatment strategies

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S297-S303. doi:https://doi.org/10.2337/dc11-s243

Antihypertensive Treatment and Blood Pressure in Diabetic and Nondiabetic Patients: The lower, the better?

Giuseppe Mancia, MD; Guido Grassi, MD; Alberto Zanchetti, MD

Abstracts

View articletitled, Antihypertensive Treatment and Blood Pressure in Diabetic and Nondiabetic Patients: The lower, the better?

Open the PDF for in another window

Topics: antihypertensive agents , blood pressure , brain , cardiovascular event , cerebrovascular accident

Diabetes Care April 2011, Vol.34, S304-S307. doi:https://doi.org/10.2337/dc11-s244

Blood Pressure: The Lower, the Better: The con side

Ehud Grossman, MD

Abstracts

View articletitled, Blood Pressure: The Lower, the Better: The con side

Open the PDF for in another window

Topics: blood pressure , cerebrovascular accident , hypertension , ischemic stroke , myocardial infarction

Diabetes Care April 2011, Vol.34, S308-S312. doi:https://doi.org/10.2337/dc11-s245

Diuretic Treatment of Hypertension

Ehud Grossman, MD; Paolo Verdecchia, MD; Ari Shamiss, MD; Fabio Angeli, MD; Gianpaolo Reboldi, MD

Abstracts

View articletitled, Diuretic Treatment of Hypertension

Open the PDF for in another window

Topics: diuretics

Diabetes Care April 2011, Vol.34, S313-S319. doi:https://doi.org/10.2337/dc11-s246

RAS Blockade for Every Diabetic Patient: Pro and Con

Luis M. Ruilope, MD; Anna Solini, MD

Abstracts

View articletitled, RAS Blockade for Every Diabetic Patient: Pro and Con

Open the PDF for in another window

Topics: angiotensin-converting enzyme inhibitors , antihypertensive agents , blood pressure , calcium channel blockers , cardiovascular diseases

Diabetes Care April 2011, Vol.34, S320-S324. doi:https://doi.org/10.2337/dc11-s248

Monitoring Kidney Function and Albuminuria in Patients With Diabetes

Hiddo J. Lambers Heerspink, PHARMD; Frank A. Holtkamp, PHARMD; Dick de Zeeuw, MD; Mordchai Ravid, MD

Abstracts

View articletitled, Monitoring Kidney Function and Albuminuria in Patients With Diabetes

Open the PDF for in another window

Topics: albuminuria , kidney

Diabetes Care April 2011, Vol.34, S325-S329. doi:https://doi.org/10.2337/dc11-s247

Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment

Eberhard Ritz, MD

Abstracts

View articletitled, Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment

Open the PDF for in another window

Topics: albuminuria , blood pressure , diabetes mellitus, type 2 , diabetic nephropathy , hemoglobin a, glycosylated

Diabetes Care April 2011, Vol.34, S330-S334. doi:https://doi.org/10.2337/dc11-s242

Obesity / Lipids

Antimicrobial-Sensing Proteins in Obesity and Type 2 Diabetes: The buffering efficiency hypothesis

José María Moreno-Navarrete, PHD; José Manuel Fernández-Real, MD

Abstracts

View articletitled, Antimicrobial-Sensing Proteins in Obesity and Type 2 Diabetes: The buffering efficiency hypothesis

Open the PDF for in another window

Topics: antimicrobials , diabetes mellitus, type 2 , lactoferrin , metabolic diseases , neutrophils

Diabetes Care April 2011, Vol.34, S335-S341. doi:https://doi.org/10.2337/dc11-s238

Meal-Related Increases in Microvascular Vasomotion Are Impaired in Obese Individuals: A potential mechanism in the pathogenesis of obesity-related insulin resistance

Amy M. Jonk, MSC; Alfons J. Houben, PHD; Nicolaas C. Schaper, MD; Peter W. de Leeuw, MD; Erik H. Serné, MD; Yvo M. Smulders, MD; Coen D. Stehouwer, MD

Abstracts

View articletitled, Meal-Related Increases in Microvascular Vasomotion Are Impaired in Obese Individuals: A potential mechanism in the pathogenesis of obesity-related insulin resistance

Open the PDF for in another window

Topics: glucose , insulin , obesity , vasomotion , insulin resistance

Diabetes Care April 2011, Vol.34, S342-S348. doi:https://doi.org/10.2337/dc11-s240

Comparative Efficiency and Safety of Pharmacological Approaches to the Management of Obesity

Vojtech Hainer, MD

Abstracts

View articletitled, Comparative Efficiency and Safety of Pharmacological Approaches to the Management of Obesity

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S349-S354. doi:https://doi.org/10.2337/dc11-s255

Cure of Type 2 Diabetes by Metabolic Surgery? A Critical Analysis of the Evidence in 2010

Guntram Schernthaner, MD; Johanna M. Brix, MD; Hans-Peter Kopp, MD; Gerit Holger Schernthaner, MD

Abstracts

View articletitled, Cure of Type 2 Diabetes by Metabolic Surgery? A Critical Analysis of the Evidence in 2010

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S355-S360. doi:https://doi.org/10.2337/dc11-s253

Bariatric Surgery for Type 2 Diabetes Reversal: The Risks

Andrei Keidar, MD

Abstracts

View articletitled, Bariatric Surgery for Type 2 Diabetes Reversal: The Risks

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S361-S266. doi:https://doi.org/10.2337/dc11-s254

Lipids in the Wrong Place: Visceral Fat and Nonalcoholic Steatohepatitis

Gianluca Perseghin, MD

Abstracts

View articletitled, Lipids in the Wrong Place: Visceral Fat and Nonalcoholic Steatohepatitis

Open the PDF for in another window

Topics: diabetes mellitus, type 2 , fatty liver , steatohepatitis, non-alcoholic , visceral fat , non-alcoholic fatty liver disease

Diabetes Care April 2011, Vol.34, S367-S370. doi:https://doi.org/10.2337/dc11-s249

Myocardial, Perivascular, and Epicardial Fat

Patricia Iozzo, MD

Abstracts

View articletitled, Myocardial, Perivascular, and Epicardial Fat

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S371-S379. doi:https://doi.org/10.2337/dc11-s250

Diabetes and Cardiovascular Disease: When it comes to lipids, statins are all you need

Rafael Bitzur, MD

Abstracts

View articletitled, Diabetes and Cardiovascular Disease: When it comes to lipids, statins are all you need

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S380-S382. doi:https://doi.org/10.2337/dc11-s256

Introduction

Introduction to the Third World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy): Outcome studies versus clinical experience in the treatment of diabetes

Itamar Raz, MD; Stefano Del Prato, MD

Abstracts

View articletitled, Introduction to the Third World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy): Outcome studies versus clinical experience in the treatment of diabetes

Open the PDF for in another window

Diabetes Care April 2011, Vol.34, S99-S100. doi:https://doi.org/10.2337/dc11-s201

Issues

Cover Image

Diabetes, Obesity and Hypertension Outcome Studies

Diabetes and Cardiovascular Disease

Diabetes

Diabetes Treatments

Hypertension

Obesity / Lipids

Introduction

Email alerts

RSS Feeds

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only